Results
1861
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1861 companies
Centessa Pharmaceuticals
Market Cap: US$1.7b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$12.62
7D
0.2%
1Y
51.1%
Cardio Diagnostics Holdings
Market Cap: US$7.5m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$4.24
7D
6.0%
1Y
-79.8%
Aurora Cannabis
Market Cap: CA$395.7m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$7.61
7D
10.1%
1Y
-13.9%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.10
7D
0.5%
1Y
4.8%
Amylyx Pharmaceuticals
Market Cap: US$484.0m
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$5.36
7D
18.6%
1Y
201.1%
China SXT Pharmaceuticals
Market Cap: US$26.6m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.61
7D
3.2%
1Y
-81.0%
Illumina
Market Cap: US$12.6b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$80.54
7D
-0.4%
1Y
-23.9%
Lantern Pharma
Market Cap: US$36.0m
Focuses on the discovery and development of oncology drug.
LTRN
US$3.35
7D
-13.2%
1Y
-46.2%
Checkpoint Therapeutics
Market Cap: US$349.7m
A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.17
7D
0.5%
1Y
126.6%
Tilray Brands
Market Cap: US$432.7m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
TLRY
US$0.45
7D
1.6%
1Y
-75.6%
SOL Global Investments
Market Cap: CA$14.7m
A private equity firm specializing in growth capital to small and mid-sized businesses.
SOL
CA$0.10
7D
5.3%
1Y
150.0%
DIOD Maker of Eco-Friendly Equipment and Nutrition
Market Cap: ₽677.1m
DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company researches, develops, manufactures, and sells nutritional supplements, pharmaceuticals, active cosmetics, and health equipment for home use.
DIOD
₽7.40
7D
0%
1Y
-13.5%
OmniAb
Market Cap: US$188.4m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.43
7D
-5.9%
1Y
-67.5%
Smart Agro -
Market Cap: ₪10.2m
Focuses on the research and development in the field of agricultural technology in Israel.
SMAG
₪2.44
7D
-4.7%
1Y
-36.3%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م1.7b
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م76.05
7D
-1.8%
1Y
-9.2%
Adagene
Market Cap: US$73.5m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$1.66
7D
-4.3%
1Y
-36.4%
Cryosite
Market Cap: AU$37.1m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.76
7D
1.3%
1Y
-22.4%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥10.4b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥19.86
7D
-0.1%
1Y
-20.3%
GeneOne Life Science
Market Cap: ₩285.0b
A biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals.
A011000
₩3,365.00
7D
44.7%
1Y
46.0%
Shanghai Junshi Biosciences
Market Cap: HK$28.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$16.98
7D
17.6%
1Y
39.4%
AstraZeneca Pharma India
Market Cap: ₹200.0b
A biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally.
506820
₹8,001.90
7D
0.7%
1Y
41.1%
ViGenCell
Market Cap: ₩60.6b
Specializes in immune cell therapy.
A308080
₩2,965.00
7D
0.5%
1Y
-33.2%
RaQualia Pharma
Market Cap: JP¥13.5b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥552.00
7D
26.3%
1Y
-0.9%
Shandong Buchang Pharmaceuticals
Market Cap: CN¥17.0b
Shandong Buchang Pharmaceuticals Co., Ltd.
603858
CN¥16.06
7D
1.1%
1Y
0.3%
Société de Therapeutique Marocaine
Market Cap: د.م10.1b
A pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco.
SOT
د.م1,444.00
7D
-1.1%
1Y
45.7%
Shandong Sito Bio-technology
Market Cap: CN¥3.5b
Researches, develops, and produces steroid biomedicine intermediates.
300583
CN¥18.40
7D
-0.1%
1Y
35.2%
Pacific Edge
Market Cap: NZ$69.0m
A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.
PEB
NZ$0.085
7D
6.3%
1Y
-15.0%
Shin Nippon Biomedical Laboratories
Market Cap: JP¥53.2b
A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.
2395
JP¥1,278.00
7D
-4.0%
1Y
-4.3%
Shenzhen Kangtai Biological Products
Market Cap: CN¥15.6b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥13.99
7D
-0.4%
1Y
-26.1%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.21
7D
1.8%
1Y
45.4%
Central Pharmaceutical No3
Market Cap: ₫1.2t
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
DP3
₫53,900.00
7D
-0.7%
1Y
-13.6%
Deva Holding
Market Cap: ₺11.3b
Manufactures, markets, and sells pharmaceutical products in Turkey.
DEVA
₺57.15
7D
-2.1%
1Y
-42.5%
Harbin Pharmaceutical Group
Market Cap: CN¥9.4b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥3.74
7D
0.8%
1Y
25.9%
Beijing Hotgen Biotech
Market Cap: CN¥11.4b
Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.
688068
CN¥126.97
7D
28.3%
1Y
341.6%
Shanghai Innostar Biotechnology
Market Cap: CN¥4.5b
Shanghai Innostar Biotechnology Co., Ltd.
688710
CN¥32.17
7D
2.1%
1Y
n/a
Kidswell Bio
Market Cap: JP¥8.2b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥187.00
7D
34.5%
1Y
52.0%